Iron Bridge Private Wealth, LLC Abb Vie Inc. Transaction History

Iron Bridge Private Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $3.29 Million - $3.95 Million	23,787 New	23,787 $3.85 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $63,878 - $79,255	-484 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$107.43 - $135.93 $107 - $135	1 Added 0.21%	484 $65,000
Q2 2021 Sep 01, 2021	BUY	$105.21 - $117.21 $105 - $117	1 Added 0.21%	483 $54,000
Q4 2020 Mar 24, 2021	BUY	$80.49 - $108.67 $38,796 - $52,378	482 New	482 $52,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Iron Bridge Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Iron Bridge Private Wealth, LLC with notifications on news.